Gilead Can't Invalidate Merck's Drug Patents In IP Fight
Ahead of an upcoming jury trial, a California federal judge on Tuesday declined a request by Gilead Sciences to invalidate two patents held by rival Merck that were purportedly infringed by...To view the full article, register now.
Already a subscriber? Click here to view full article